NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

BSB, great list - thanks for providing it. I’ve been thinking about finding this list and defining for myself what the term Big Pharma actually applies to as far as specific companies.

I would think that one could whittle the list down in terms of potential acquirers considerably by applying several filters.


Which BPs focus on both oncology and immunology? If they don’t do both, then I doubt they’re looking at a small company like NWBO which doesn’t bring enough expertise with them to really scale this technology up across the multiple indications (in terms of best indications in a medical sense and potential ROI,etc, not manufacturing) that are possible and which doesn’t have the broad immunological expertise to really help decide which other immune approaches might be best in combination. I know we could all offer some suggestions based on current ICIs that are being tested but that seems like a fly-by-the-seat of ones pants approach for a BP. I would think a BP would like to have that expertise available as part of what it does in its approach to the oncology market.

A second filter would be market cap. If you think NWBO is going to be bought out for X billion then I would think the buyer should be significantly bigger than that. Past BOs would give a good indication of what a realistic ratio of buyers to seller market cap might be.

There are probably other factors that would come into play but these two popped into my head immediately.

Just some food for thought.